Rationale for surgery as the first step in the multimodality treatment of small cell lung cancer (SCLC)

• Published in: Journal of chemotherapy (Florence) Vol. 1; no. 3; p. 147
• Main Author: Karrer, K
• Format: Journal Article
• Language: English
• Published: England 01-06-1989
• Subjects: Carcinoma, Small Cell - drug therapy; Carcinoma, Small Cell - surgery; Humans; Lung Neoplasms - drug therapy; Lung Neoplasms - surgery
• ISSN: 1120-009X
• DOI: 10.1080/1120009X.1989.11738882

The role of surgery has to be reconsidered in combination with chemo/radiotherapy for patients with SCLC at early stages, determined by the pTNM-staging system. This combined multimodality treatment can be seen as a model-like example for the most effective progress gained during the last 20 years. Surgery followed by chemotherapy is used in ongoing cooperative studies. In other trials, chemotherapy is followed by surgery for responding patients. It seems reasonable to expect that after appropriate observation times the comparison of these ongoing trials would most probably lead to the conclusion that for stage I, II surgery should be the first step followed by chemo- and radiotherapy, whereas for stage III debulking chemotherapy should be given to distinguish responding patients, who may thereafter receive adjuvant surgery.